343 related articles for article (PubMed ID: 11038423)
21. Fine-needle aspiration cytology to distinguish dysplasia from hepatocellular carcinoma with different grades.
Lin CC; Lin CJ; Hsu CW; Chen YC; Chen WT; Lin SM
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e146-52. PubMed ID: 17532784
[TBL] [Abstract][Full Text] [Related]
22. Podocalyxin-like protein 1 expression in primary hepatic tumours and tumour-like lesions.
Heukamp LC; Fischer HP; Schirmacher P; Chen X; Breuhahn K; Nicolay C; Büttner R; Gütgemann I
Histopathology; 2006 Sep; 49(3):242-7. PubMed ID: 16918970
[TBL] [Abstract][Full Text] [Related]
23. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules.
Libbrecht L; Severi T; Cassiman D; Vander Borght S; Pirenne J; Nevens F; Verslype C; van Pelt J; Roskams T
Am J Surg Pathol; 2006 Nov; 30(11):1405-11. PubMed ID: 17063081
[TBL] [Abstract][Full Text] [Related]
24. Fine needle aspiration cytodiagnosis of liver tumors.
Kuo FY; Chen WJ; Lu SN; Wang JH; Eng HL
Acta Cytol; 2004; 48(2):142-8. PubMed ID: 15085744
[TBL] [Abstract][Full Text] [Related]
25. Immunocytochemical staining of fine-needle aspiration biopsies of the liver as a diagnostic tool for hepatocellular carcinoma.
Johnson DE; Powers CN; Rupp G; Frable WJ
Mod Pathol; 1992 Mar; 5(2):117-23. PubMed ID: 1374187
[TBL] [Abstract][Full Text] [Related]
26. Unusual reticulin staining pattern in well-differentiated hepatocellular carcinoma.
Hong H; Patonay B; Finley J
Diagn Pathol; 2011 Feb; 6():15. PubMed ID: 21338527
[TBL] [Abstract][Full Text] [Related]
27. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma.
Nouso K; Urabe Y; Higashi T; Nakatsukasa H; Hino N; Ashida K; Kinugasa N; Yoshida K; Uematsu S; Tsuji T
Cancer; 1996 Jul; 78(2):232-36. PubMed ID: 8673997
[TBL] [Abstract][Full Text] [Related]
28. CD 34 expression in chronic and neoplastic liver diseases.
Di Carlo I; Fraggetta F; Lombardo R; Azzarello G; Vasquez E; Puleo S
Panminerva Med; 2002 Dec; 44(4):365-7. PubMed ID: 12434120
[TBL] [Abstract][Full Text] [Related]
29. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
Shiran MS; Isa MR; Sherina MS; Rampal L; Hairuszah I; Sabariah AR
Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797
[TBL] [Abstract][Full Text] [Related]
30. Immunocytochemical evaluation of liver fine-needle aspirations.
Bedrossian CW; Davila RM; Merenda G
Arch Pathol Lab Med; 1989 Nov; 113(11):1225-30. PubMed ID: 2479356
[TBL] [Abstract][Full Text] [Related]
31. Highly well differentiated hepatocellular carcinoma and benign hepatocellular lesions. Can they be distinguished on fine needle aspiration biopsy?
Wee A; Nilsson B
Acta Cytol; 2003; 47(1):16-26. PubMed ID: 12585026
[TBL] [Abstract][Full Text] [Related]
32. Polyclonal carcinoembryonic antigen staining in the cytologic differential diagnosis of primary and metastatic hepatic malignancies.
Wolber RA; Greene CA; Dupuis BA
Acta Cytol; 1991; 35(2):215-20. PubMed ID: 1709323
[TBL] [Abstract][Full Text] [Related]
33. Value of glypican 3 immunostaining in the diagnosis of hepatocellular carcinoma on needle biopsy.
Anatelli F; Chuang ST; Yang XJ; Wang HL
Am J Clin Pathol; 2008 Aug; 130(2):219-23. PubMed ID: 18628090
[TBL] [Abstract][Full Text] [Related]
34. Fine needle aspiration of the liver. Significance of hepatocytic naked nuclei in the diagnosis of hepatocellular carcinoma.
Pedio G; Landolt U; Zöbeli L; Gut D
Acta Cytol; 1988; 32(4):437-42. PubMed ID: 2840789
[TBL] [Abstract][Full Text] [Related]
35. Fine needle aspiration biopsy of hepatocellular carcinoma. Value of immunocytochemical and ultrastructural studies.
Guindi M; Yazdi HM; Gilliatt MA
Acta Cytol; 1994; 38(3):385-91. PubMed ID: 7514832
[TBL] [Abstract][Full Text] [Related]
36. Annexin A2 as a differential diagnostic marker of hepatocellular tumors.
Longerich T; Haller MT; Mogler C; Aulmann S; Lohmann V; Schirmacher P; Brand K
Pathol Res Pract; 2011 Jan; 207(1):8-14. PubMed ID: 20971570
[TBL] [Abstract][Full Text] [Related]
37. Distinguishing well-differentiated hepatocellular carcinoma from benign liver by the physical features of fine-needle aspirates.
Yang GC; Yang GY; Tao LC
Mod Pathol; 2004 Jul; 17(7):798-802. PubMed ID: 15044922
[TBL] [Abstract][Full Text] [Related]
38. Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas.
Wang XY; Degos F; Dubois S; Tessiore S; Allegretta M; Guttmann RD; Jothy S; Belghiti J; Bedossa P; Paradis V
Hum Pathol; 2006 Nov; 37(11):1435-41. PubMed ID: 16949914
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical stains of proliferating cell nuclear antigen, insulin-like growth factor 2 and clusterin help distinguish malignant from benign liver nodular lesions.
Lai JP; Chen ZM; Lok T; Chan OT; Himmelfarb E; Zhai Q; Lin F; Wang HL
J Clin Pathol; 2014 Jun; 67(6):464-9. PubMed ID: 24407433
[TBL] [Abstract][Full Text] [Related]
40. A triple stain of reticulin, glypican-3, and glutamine synthetase: a useful aid in the diagnosis of liver lesions.
Swanson BJ; Yearsley MM; Marsh W; Frankel WL
Arch Pathol Lab Med; 2015 Apr; 139(4):537-42. PubMed ID: 25822763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
